With Celloid, Easier Culture with Superior Reproducibility and Relevance
Our visions
and expertise
We provide the optimal 3D cell culture solution.
Our novel technology allows the quality controlled long-term culture of organoids with high reproducibility and relevance.
Our R&D continues to facilitate the use of organoids/spheroids in drug development and diagnostics, further in regenerative medicine.
Our novel technology allows the quality controlled long-term culture of organoids with high reproducibility and relevance.
Our R&D continues to facilitate the use of organoids/spheroids in drug development and diagnostics, further in regenerative medicine.
3D cell culture system
NestWell®
OrgaNest®
Regenerative medicine
Co-development
CDMO
Drug discovery / Disease modeling
Alternative methods to animal testing
Our History
2025
- Jul. Patent registration “Cartridge for adherent cell culture, and cell culture device comprising the same“
- Jun. Selected Inno-Tech Development Program of Pohang Innopolis (Korea Innovation Foundation)
- Jun. Selected Seoul BioHUB’s resident start-ups
- May. Selected “University Research Institute-Startup Joint Innovative R&D“ program (Ministry of Science and ICT)
- Feb. Patent registration “3D cell aggregate culture apparatus and 3D cell aggregate culture method using the same“
2024
Launch of automated 3D cell culture system OrgaNest® Basic+
- Sep. First Installation of OrgaNest® Basic+ at the Center for 3D Organ Printing and Stem Cells at POSTECH
- Sep. Patent registration “Method for differentiation to stem cell derived hyaline cartilage spheroid and uses thereof“
- May. Launched OrgaNest® Basic+
- Apr. Selected ScaleUp-TIPS program
- Apr. Selected R&D program (Korean Fund for Regenerative Medicine)
2023
- Dec. Raising KRW 2.4 Billion in pre-A Round Funding
- Apr. Selected R&D project “Development of a 3D Bioreactor for In Situ Formation of Uniform Cell Aggregation, Proliferation, and Differentiation Using a Permeable Membrane Scaffold and Flow-Through System“ (Ministry of Trade, Industry and Energy)
- Feb. Acquisition of Medical Devices Quality Management System Certification (ISO 13485)
2022
Launch of 3D cell culture platform NestWell®
- Dec. Business-Affiliated Research Institutes Certification
- Dec. Establishment of R&D center (Seoul)
- Nov. Venture Enterprise Certification
- Jun. TIPS program & Angel investment
2021
Foundation of Celloid Co., Ltd.
Copyright by Celloid 2023. All rights reserved.
Copyright by Celloid 2023. All rights reserved.